Japan Private Equity:Additional investment in Curadim Pharma Co., Ltd., a pipeline-type drug-discovery venture that develops new drugs for intractable diseases
Jun 05, 2018
byInvestment in Japan
Private Equity in Japan
Innovation Network Corporation of Japan (INCJ) announced that in line with the business progress of Curadim Pharma Co., Ltd. (Curadim Pharma), a venture business that develops new drugs for intractable diseases, INCJ decided to provide support of up to JPY1.2 billion by purchasing the shares of Curadim Pharma issued through third-party allocation and has actually executed an additional investment of JPY900 million. Further, in addition to SMBC Venture Capital Co., Ltd., an existing shareholder of Curadim Pharma, DBJ Capital Co., Ltd. and Yamaguchi Capital Co., Ltd. have newly participated in the investment. The funding will be used for research and development of new drugs.